The startup has developed a smart surgical needle that utilizes real-time X-ray guidance and ultrasound energy for minimally invasive tumor detection and ablation. This technology enables precise tumor treatment near critical anatomy while minimizing damage to surrounding vital organs and tissue.
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current surgical procedures for tumor ablation near critical anatomy often lack precision, leading to potential damage to surrounding healthy tissue and vital organs. Real-time visualization and accurate targeting of tumors during minimally invasive procedures remain a significant challenge.
Solution
The startup offers a smart surgical needle that integrates real-time X-ray guidance with ultrasound energy for precise tumor detection and ablation. This technology allows surgeons to navigate the needle with enhanced accuracy, enabling targeted treatment of tumors located near critical structures. By combining advanced imaging and energy delivery, the needle minimizes collateral damage to surrounding tissues and organs during minimally invasive procedures. The system aims to improve patient outcomes by enhancing the precision and safety of tumor ablation.
Target Audience
The primary target audience includes surgeons specializing in oncology, interventional radiology, and other surgical disciplines requiring precise tumor ablation techniques.
Features
- Real-time X-ray guidance for precise needle placement and navigation.
- Integrated ultrasound energy for targeted tumor ablation.
- Minimally invasive design to reduce patient trauma and recovery time.
- Enhanced visualization capabilities for accurate tumor detection.
- Compatibility with standard surgical equipment and workflows.